The Price-to-Earnings (P/E) ratio is the most widely used stock valuation metric in the world — and the most misunderstood. It tells you how much investors are paying for each rupee of a company's earnings. Used correctly, it's a powerful lens for comparing valuations. Used naively, it leads to buying expensive 'cheap' stocks and selling cheap 'expensive' ones.
P/E Ratio = Market Price per Share ÷ Earnings per Share (EPS)
Or equivalently: P/E = Market Capitalisation ÷ Net Profit
If a stock trades at ₹500 and its EPS (earnings per share) for the trailing 12 months is ₹25, its P/E is 20 — meaning investors are paying ₹20 for every ₹1 of current earnings.
| Stock | Price (₹) | EPS (₹) | P/E | Interpretation |
|---|---|---|---|---|
| Company A | 500 | 25 | 20x | Paying ₹20 per ₹1 of earnings |
| Company B | 1,000 | 20 | 50x | High growth expected; expensive by earnings |
| Company C | 200 | 40 | 5x | Very cheap, or earnings at risk of declining |
Neither is "better" — use both. A company with trailing P/E of 80x and forward P/E of 25x is pricing in very high growth; whether that's justified depends on whether you believe the estimates.
The Nifty 50 P/E ratio is a key market-level valuation signal. Historical data since 2000:
| Nifty P/E Zone | Historical Signal | Implication for Long-term SIP Investors |
|---|---|---|
| Below 15x | Historically cheap (market crashes, 2003, 2009, 2020) | Excellent time to invest aggressively; lumpsum opportunities |
| 15x – 20x | Fair value zone (long-term average ~20x) | Continue SIPs normally; no urgency to increase or decrease |
| 20x – 25x | Moderately expensive; growth must justify it | Continue SIPs; be selective on new lumpsum investments |
| Above 25x | Historically expensive (2000 IT bubble, 2021 post-COVID rally) | Tread carefully with new lumpsum; continue SIPs; review portfolio quality |
P/E ratios vary dramatically by sector. Comparing a bank's P/E to a software company's P/E is meaningless — each sector has its own norm:
| Sector | Typical P/E Range | Why |
|---|---|---|
| FMCG (HUL, Nestle, Britannia) | 40–70x | Stable earnings, premium for predictability |
| IT Services (TCS, Infosys) | 25–35x | High margins, dollar revenue, good growth |
| Private Banks (HDFC, Kotak) | 15–25x | P/B more relevant than P/E for banks |
| PSU Banks | 5–12x | Lower ROE, government ownership discount |
| Auto (Maruti, M&M) | 20–30x | Cyclical; P/E varies with cycle |
| Pharma (Sun, Cipla) | 25–40x | R&D investment, patent value |
| Real Estate | Often negative or not meaningful | Use EV/EBITDA or NAV instead |
| New-age tech (Zomato, Paytm) | Not meaningful (negative EPS) | Use Price/Sales or EV/Revenue |
P/E is a powerful but incomplete metric. It cannot tell you:
This is why professional analysts use P/E alongside PEG ratio (P/E divided by growth rate), EV/EBITDA, Price/Book, and DCF valuation. See our DCF valuation guide for a more complete framework.
PEG = P/E ÷ Expected EPS Growth Rate (in %)
A PEG below 1 is often considered undervalued (paying less than 1x P/E per unit of growth). Example: Company growing at 30% annually with a P/E of 25x has a PEG of 0.83 — arguably cheap. Same P/E but growing at 10% has a PEG of 2.5 — expensive relative to growth. PEG is more useful than P/E alone for growth stocks but still relies on forecast accuracy.
Use the current official instrument, portal or regulator publication before acting. This panel separates the category authority from page-specific references.
The prior page did not embed a page-specific external source. The category authority above is the minimum verification starting point; a specific instrument should be added during the next substantive editorial review.